Concord Biotech Limited

Concord Biotech Limited is an R&D-based vertically integrated biotechnology company having state-of-the-art manufacturing facilities, offering fermentation & semi-synthetic APIs and Finished Dosage forms. Concord practices cGMP and its facilities are been inspected by Global Regulatory agencies like USFDA, EU-GMP, Japanese AFM, Local FDA, Korean FDA. Concord has built up more than 20 dedicated API manufacturing blocks, having over 500 KL fermentation capacity and having separate manufacturing unit for Finished Dosage forms. Concord has diversified portfolio of APIs in the area of Immunosuppressants, Oncology, Anti-bacterial, Anti-fungal, Animal Health, Enzymes and statins. Concord also offers Contract Research & Manufacturing services of APIs in the area of fermentation & semi-synthetic molecules. On Finished dosage forms, Concord is initially focusing on solid oral dosage & oral liquids of Immunosuppressants followed by solid oral dosage of Oncology & General products and future expansion in Specialty formulations.